Overview
400mcg Sublingual Misoprostol as First Line Treatment
Status:
Completed
Completed
Trial end date:
2012-08-01
2012-08-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Gynuity Health ProjectsTreatments:
Misoprostol
Criteria
Inclusion Criteria:- uterine size less than 12 weeks lmp
- open cervical os
- current or past vaginal bleeding
- willing to provide contact information for follow-up
- over 18 or with guardian consent
Exclusion Criteria:
- suspicion of ectopic pregnancy
- intrauterine device in place
- bad general health (infection, anemia, shoc)